0001127602-12-026131.txt : 20120911 0001127602-12-026131.hdr.sgml : 20120911 20120911180427 ACCESSION NUMBER: 0001127602-12-026131 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120910 FILED AS OF DATE: 20120911 DATE AS OF CHANGE: 20120911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KALKSTEIN MICHAEL CENTRAL INDEX KEY: 0001183216 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08597 FILM NUMBER: 121086412 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COOPER COMPANIES INC CENTRAL INDEX KEY: 0000711404 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 942657368 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 6140 STONERIDGE MALL RD STREET 2: STE 590 CITY: PLEASANTON STATE: CA ZIP: 94588 BUSINESS PHONE: 9254603600 MAIL ADDRESS: STREET 1: 6140 STONERIDGE MALL ROAD STREET 2: SUITE 590 CITY: PLEASANTON STATE: CA ZIP: 94588 FORMER COMPANY: FORMER CONFORMED NAME: COOPERVISION INC DATE OF NAME CHANGE: 19870701 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2012-09-10 0000711404 COOPER COMPANIES INC COO 0001183216 KALKSTEIN MICHAEL 6140 STONERIDGE MALL DRIVE SUITE 590 PLEASANTON CA 94588 1 Common Stock 2012-09-10 4 M 0 17500 43.98 A 42100 D Common Stock 2012-09-10 4 M 0 10000 17.09 A 52100 D Common Stock 2012-09-10 4 M 0 7500 28.52 A 59600 D Common Stock 2012-09-10 4 S 0 35000 91.865 D 24600 D Common Stock 0 I Pension Fund Non-employee Director Stock Option (Right to Buy) 43.98 2012-09-10 4 M 0 17500 0 D 2013-11-03 Common Stock 17500 0 D Non-employee Director Stock Option (Right to Buy) 17.09 2012-09-10 4 M 0 10000 0 D 2018-11-02 Common Stock 10000 0 D Non-employee Director Stock Option (Right to Buy) 28.52 2012-09-10 4 M 0 7500 0 D 2010-11-02 2019-11-01 Common Stock 7500 0 D Sale price represents an average of sale prices ranging from $91.60 to $92.51. These shares are held by Mr. Kalkstein in a pension fund. Vests when average of closing prices during any 30 consecutive trading days after the date of grant reaches $48.37. All shares granted under this option are currently exercisable. /s/ Michael H. Kalkstein 2012-09-10